Biomarkers in Non-Small Cell Lung Cancers: Indian Consensus Guidelines for Molecular Testing-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Biomarkers in Non-Small Cell Lung Cancers: Indian Consensus Guidelines for Molecular Testing

Published:2019-03-12 Issue:4 Volume:36 Page:766-785
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Prabhash Kumar,Advani Suresh H.,Batra Ullas,Biswas Bivas,Chougule Anuradha,Ghosh Mithua,Muddu Vamshi Krishna,Sahoo T. P.,Vaid Ashok K.

Funder

AstraZeneca Pharma India Ltd.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12325-019-00903-y.pdf

Reference123 articles.

1. Parikh PM, Ranade AA, Govind B, et al. Lung cancer in India: current status and promising strategies. South Asian J Cancer. 2016;5(3):93–5.

2. Desai C, Mehta A, Mishra D. Usage patterns of biomarkers in non-small-cell lung cancer patients in India: findings from a systematic review and survey. Lung India. 2014;31(3):249–59.

3. Malik PS, Raina V. Lung cancer: prevalent trends & emerging concepts. Indian J Med Res. 2015;141(1):5–7.

4. Noronha V, Pinninti R, Patil VM, Joshi A, Prabhash K. Lung cancer in the Indian subcontinent. South Asian J Cancer. 2016;5(3):95–103.

5. Nair C, Mathew A, George P. Lung cancer: presentation and pattern of care in a cancer center in South India. Indian J Cancer. 2017;54(1):164–8.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microfluidics‐based EGFR mutation detection and its implication in the resource‐limited clinical setting;International Journal of Experimental Pathology;2024-05-08

2. Efficacy of targeted therapy in patients with non-small cell lung cancer harboring very rare mutations in EGFR exon 18;Translational Lung Cancer Research;2024-04

3. Predicting EGFR gene mutation status in lung adenocarcinoma based on multifeature fusion;Biomedical Signal Processing and Control;2023-07

4. Navigating patient journey in early diagnosis of lung cancer in India;Lung India;2023

5. All EGFR mutations are (not) created equal: focus on uncommon EGFR mutations;Journal of Cancer Research and Clinical Oncology;2022-05-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3